Original Study: Transjugular Intrahepatic Portosystemic Shunt as a Bridge to Abdominal Surgery in Cirrhotic Patients.


Journal

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
ISSN: 1873-4626
Titre abrégé: J Gastrointest Surg
Pays: United States
ID NLM: 9706084

Informations de publication

Date de publication:
12 2019
Historique:
received: 18 07 2018
accepted: 08 11 2018
pubmed: 2 3 2019
medline: 26 8 2020
entrez: 2 3 2019
Statut: ppublish

Résumé

Transjugular intrahepatic portosystemic shunt (TIPS) has been suggested to reduce portal hypertension-associated complications in cirrhotic patients undergoing abdominal surgery. The aim of this study was to compare postoperative outcome in cirrhotic patients with and without specific preoperative TIPS placement, following elective extrahepatic abdominal surgery. Patients were retrospectively included from 2005 to 2016 in four centers. Patients who underwent preoperative TIPS (n = 66) were compared to cirrhotic control patients without TIPS (n = 68). Postoperative outcome was analyzed using propensity score with inverse probability of treatment weighting analysis. Overall, colorectal surgery accounted for 54% of all surgical procedure. TIPS patients had a higher initial Child-Pugh score (6[5-12] vs. 6[5-9], p = 0.043) and received more beta-blockers (65% vs. 22%, p < 0.001). In TIPS group, 56 (85%) patients managed to undergo planned surgery. Preoperative TIPS was associated with less postoperative ascites (hazard ratio = 0.330 [0.140-0.780]). Severe postoperative complications (Clavien-Dindo > 2) and 90-day mortality were similar between TIPS and no-TIPS groups (18% vs. 23%, p = 0.392, and 7.5% vs. 7.8%, p = 0.644, respectively). Preoperative TIPS placement yielded an 85% operability rate with satisfying postoperative outcomes. No significant differences were found between TIPS and no-TIPS groups in terms of severe postoperative complications and mortality, although TIPS patients probably had worse initial portal hypertension.

Sections du résumé

BACKGROUND
Transjugular intrahepatic portosystemic shunt (TIPS) has been suggested to reduce portal hypertension-associated complications in cirrhotic patients undergoing abdominal surgery. The aim of this study was to compare postoperative outcome in cirrhotic patients with and without specific preoperative TIPS placement, following elective extrahepatic abdominal surgery.
METHODS
Patients were retrospectively included from 2005 to 2016 in four centers. Patients who underwent preoperative TIPS (n = 66) were compared to cirrhotic control patients without TIPS (n = 68). Postoperative outcome was analyzed using propensity score with inverse probability of treatment weighting analysis.
RESULTS
Overall, colorectal surgery accounted for 54% of all surgical procedure. TIPS patients had a higher initial Child-Pugh score (6[5-12] vs. 6[5-9], p = 0.043) and received more beta-blockers (65% vs. 22%, p < 0.001). In TIPS group, 56 (85%) patients managed to undergo planned surgery. Preoperative TIPS was associated with less postoperative ascites (hazard ratio = 0.330 [0.140-0.780]). Severe postoperative complications (Clavien-Dindo > 2) and 90-day mortality were similar between TIPS and no-TIPS groups (18% vs. 23%, p = 0.392, and 7.5% vs. 7.8%, p = 0.644, respectively).
CONCLUSIONS
Preoperative TIPS placement yielded an 85% operability rate with satisfying postoperative outcomes. No significant differences were found between TIPS and no-TIPS groups in terms of severe postoperative complications and mortality, although TIPS patients probably had worse initial portal hypertension.

Identifiants

pubmed: 30820792
doi: 10.1007/s11605-018-4053-x
pii: 10.1007/s11605-018-4053-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2383-2390

Références

J Am Coll Surg. 2001 Jul;193(1):46-51
pubmed: 11442253
Dig Liver Dis. 2017 Feb;49(2):121-137
pubmed: 27884494
Stat Med. 2009 Nov 10;28(25):3083-107
pubmed: 19757444
Hepatology. 2017 Jan;65(1):310-335
pubmed: 27786365
Dig Liver Dis. 2015 Jan;47(1):81-4
pubmed: 25445406
Dis Colon Rectum. 2008 Aug;51(8):1225-31
pubmed: 18521677
Hepatology. 2010 Jan;51(1):306
pubmed: 19902484
Ann Surg. 2005 Dec;242(6):824-8, discussion 828-9
pubmed: 16327492
AJR Am J Roentgenol. 2012 Oct;199(4):746-55
pubmed: 22997364
Dis Colon Rectum. 2009 Aug;52(8):1367-74
pubmed: 19617746
Hepatology. 2000 Apr;31(4):864-71
pubmed: 10733541
J Am Coll Surg. 2009 Jan;208(1):96-103
pubmed: 19228510
Lancet. 2014 May 17;383(9930):1749-61
pubmed: 24480518
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Diagn Interv Imaging. 2015 Jul-Aug;96(7-8):745-55
pubmed: 26094039
Gastroenterology. 2006 May;130(6):1652-60
pubmed: 16697729
Am J Surg. 2012 May;203(5):589-593
pubmed: 22521048
Multivariate Behav Res. 2011 May;46(3):399-424
pubmed: 21818162
N Engl J Med. 2015 Apr 23;372(17):1629-38
pubmed: 25776936
Baillieres Clin Gastroenterol. 1997 Jun;11(2):221-41
pubmed: 9395745
Eur J Gastroenterol Hepatol. 2011 Jan;23(1):51-9
pubmed: 21084989
HPB (Oxford). 2018 Feb;20(2):101-109
pubmed: 29110990
Trans Am Clin Climatol Assoc. 2010;121:192-204; discussion 205
pubmed: 20697561
Am J Gastroenterol. 2007 Sep;102(9):2086-102
pubmed: 17727436
J Gastroenterol Hepatol. 2012 Oct;27(10):1569-75
pubmed: 22694313

Auteurs

N Tabchouri (N)

Department of Digestive Surgery, Hepatobiliary Surgery and Liver Transplantation, University Hospital of Tours, CHU Tours, Avenue de la République, F37042, Tours, France.
FHU Support, F37000, Tours, France.

L Barbier (L)

Department of Digestive Surgery, Hepatobiliary Surgery and Liver Transplantation, University Hospital of Tours, CHU Tours, Avenue de la République, F37042, Tours, France.
FHU Support, F37000, Tours, France.

B Menahem (B)

Department of Digestive Surgery, University Hospital of Caen, Caen Cedex, France.

J-M Perarnau (JM)

Department of Hepatology, University Hospital of Tours, CHU Tours, F37042, Tours, France.

F Muscari (F)

Department of Surgery, Hôpital Rangueil, Toulouse, France.

N Fares (N)

Department of Hepatology and Gastroenterology, Purpan Hospital, University Hospital of Toulouse, Place du Docteur Baylac TSA 40031, 31059, Toulouse Cedex 9, France.

L D'Alteroche (L)

Department of Hepatology, University Hospital of Tours, CHU Tours, F37042, Tours, France.

P-J Valette (PJ)

Department of Digestive Diseases, Hospices Civils de Lyon, Hôpital Edouard Herriot, Université Claude Bernard Lyon 1, Lyon, France.

J Dumortier (J)

Department of Digestive Diseases, Hospices Civils de Lyon, Hôpital Edouard Herriot, Université Claude Bernard Lyon 1, Lyon, France.

A Alves (A)

Department of Digestive Surgery, University Hospital of Caen, Caen Cedex, France.

J Lubrano (J)

Department of Digestive Surgery, University Hospital of Caen, Caen Cedex, France.

C Bureau (C)

Department of Hepatology and Gastroenterology, Purpan Hospital, University Hospital of Toulouse, Place du Docteur Baylac TSA 40031, 31059, Toulouse Cedex 9, France.

Ephrem Salamé (E)

Department of Digestive Surgery, Hepatobiliary Surgery and Liver Transplantation, University Hospital of Tours, CHU Tours, Avenue de la République, F37042, Tours, France. e.salame@chu-tours.fr.
FHU Support, F37000, Tours, France. e.salame@chu-tours.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH